In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

Rebecca L. Read; Lauren E. Haydu; Robyn P.M. Saw; Michael J. Quinn; Kerwin F. Shannon; Andrew J. Spillane; Jonathan R. Stretch; Richard A Scolyer; John F. Thompson

doi:10.1245/s10434-014-4100-0

Related publications

Article2022

Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases

Anna Lawless, David J. Coker, Serigne Lo, Tasnia Ahmed, Richard A Scolyer, Sydney Ch’ng, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Robyn P.M. Saw

Article2023

A sheep in wolf's clothing: Agminated blue naevi masquerading as in‐transit melanoma metastases

Nicholas Allen, Elizabeth C. Paver, Nita Agar, Richard A Scolyer, Fergal J. Moloney

Article2022

ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases

Anna Lawless, David J. Coker, Serigne Lo, Tasnia Ahmed, Richard A Scolyer, Sydney Ch’ng, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Robyn P.M. Saw

Article2009

Lymphadenectomy for Melanoma in the Clinically N1 Neck

Sir Nicholas White, Lok Huei Yap, Shekhar Srivastava

Journal of Craniofacial Surgery

Article2022

Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

Alistair J. Cochran, Duan‐Ren Wen, Rongrong Huang, Payam Abrishami, Chandra Smart, Scott W. Binder, Richard A Scolyer, John F. Thompson, Stacey L. Stern, Lisa Van Kreuningen, David Elashoff, Myung‐Shin Sim, Hong Wang, Mark B. Faries, John M. Kirkwood, John Daly, Michael Kutner, Martin Mihm, Gary J. Smith, M. M. Urist, Norman Beegun

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

Discussion(0)

Related publications

Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases

A sheep in wolf's clothing: Agminated blue naevi masquerading as in‐transit melanoma metastases

ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases

Lymphadenectomy for Melanoma in the Clinically N1 Neck

Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)